Michelle Wennerholm

622 total citations
18 papers, 482 citations indexed

About

Michelle Wennerholm is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michelle Wennerholm has authored 18 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 7 papers in Molecular Biology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michelle Wennerholm's work include Cannabis and Cannabinoid Research (9 papers), Alcohol Consumption and Health Effects (5 papers) and Circadian rhythm and melatonin (4 papers). Michelle Wennerholm is often cited by papers focused on Cannabis and Cannabinoid Research (9 papers), Alcohol Consumption and Health Effects (5 papers) and Circadian rhythm and melatonin (4 papers). Michelle Wennerholm collaborates with scholars based in United States, Sweden and Belgium. Michelle Wennerholm's co-authors include Michael Webb, Mark J. Karbarz, J. Guy Breitenbucher, John M. Keith, James A. Palmer, Sandra R. Chaplan, Lin Luo, Brian Scott, Pascal Bonaventure and Timothy W. Lovenberg and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Anesthesia & Analgesia and Frontiers in Pharmacology.

In The Last Decade

Michelle Wennerholm

18 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle Wennerholm United States 12 216 142 135 117 111 18 482
Ann M. Decker United States 17 179 0.8× 60 0.4× 422 3.1× 47 0.4× 34 0.3× 58 945
Banu Cahide Tel Türkiye 17 106 0.5× 93 0.7× 160 1.2× 27 0.2× 14 0.1× 35 826
Giulia Donvito United States 11 354 1.6× 67 0.5× 150 1.1× 31 0.3× 6 0.1× 19 581
K. Fukatsu Japan 11 28 0.1× 172 1.2× 201 1.5× 279 2.4× 153 1.4× 18 749
Amey Dhopeshwarkar United States 12 458 2.1× 72 0.5× 169 1.3× 39 0.3× 4 0.0× 13 643
Leanne Cutler United Kingdom 8 86 0.4× 214 1.5× 156 1.2× 192 1.6× 122 1.1× 10 659
Amaia M. Erdozain Spain 14 87 0.4× 38 0.3× 166 1.2× 29 0.2× 22 0.2× 34 430
Angela C. Doran United States 14 68 0.3× 33 0.2× 213 1.6× 86 0.7× 14 0.1× 25 642
Sonya L. Palmer United States 10 259 1.2× 31 0.2× 119 0.9× 37 0.3× 7 0.1× 11 463
Thomas F. Gamage United States 17 639 3.0× 77 0.5× 254 1.9× 28 0.2× 9 0.1× 33 917

Countries citing papers authored by Michelle Wennerholm

Since Specialization
Citations

This map shows the geographic impact of Michelle Wennerholm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Wennerholm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Wennerholm more than expected).

Fields of papers citing papers by Michelle Wennerholm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Wennerholm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Wennerholm. The network helps show where Michelle Wennerholm may publish in the future.

Co-authorship network of co-authors of Michelle Wennerholm

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Wennerholm. A scholar is included among the top collaborators of Michelle Wennerholm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Wennerholm. Michelle Wennerholm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
McCarver, Stefan J., Luke Elizabeth Hanna, Aaron A. Thompson, et al.. (2024). Structure-Based Optimization of Selective and Brain Penetrant CK1δ Inhibitors for the Treatment of Circadian Disruptions. ACS Medicinal Chemistry Letters. 15(4). 486–492. 1 indexed citations
2.
Keith, John M., W. M. Jones, Mark Seierstad, et al.. (2020). Heteroarylureas with fused bicyclic diamine cores as inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 30(20). 127463–127463. 4 indexed citations
3.
Wang, Lien, Grace Lee, Amy Y. Shih, et al.. (2019). Mutagenesis of GPR139 reveals ways to create gain or loss of function receptors. Pharmacology Research & Perspectives. 7(1). e00466–e00466. 2 indexed citations
4.
Bonaventure, Pascal, Christine Dugovic, Brock T. Shireman, et al.. (2017). Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation. Frontiers in Pharmacology. 8. 357–357. 35 indexed citations
5.
Yun, Sujin, Michelle Wennerholm, Jonathan Shelton, et al.. (2017). Selective Inhibition of Orexin-2 Receptors Prevents Stress-Induced ACTH Release in Mice. Frontiers in Behavioral Neuroscience. 11. 83–83. 24 indexed citations
6.
Keith, John M., Mark S. Tichenor, Richard L. Apodaca, et al.. (2016). The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(13). 3109–3114. 11 indexed citations
7.
Dvorak, Curt A., Heather Coate, Diane Nepomuceno, et al.. (2015). Identification and SAR of Glycine Benzamides as Potent Agonists for the GPR139 Receptor. ACS Medicinal Chemistry Letters. 6(9). 1015–1018. 30 indexed citations
8.
Bonaventure, Pascal, Sujin Yun, Philip L. Johnson, et al.. (2015). A Selective Orexin-1 Receptor Antagonist Attenuates Stress-Induced Hyperarousal without Hypnotic Effects. Journal of Pharmacology and Experimental Therapeutics. 352(3). 590–601. 74 indexed citations
9.
Keith, John M., W. M. Jones, Mark S. Tichenor, et al.. (2015). Preclinical Characterization of the FAAH Inhibitor JNJ-42165279. ACS Medicinal Chemistry Letters. 6(12). 1204–1208. 47 indexed citations
10.
Keith, John M., W. M. Jones, Mark Seierstad, et al.. (2014). Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 24(3). 737–741. 24 indexed citations
11.
Keith, John M., Natalie A. Hawryluk, Richard L. Apodaca, et al.. (2014). 1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 24(5). 1280–1284. 11 indexed citations
12.
Tichenor, Mark S., John M. Keith, W. M. Jones, et al.. (2012). Heteroaryl urea inhibitors of fatty acid amide hydrolase: Structure–mutagenicity relationships for arylamine metabolites. Bioorganic & Medicinal Chemistry Letters. 22(24). 7357–7362. 20 indexed citations
13.
Keith, John M., Richard L. Apodaca, Mark S. Tichenor, et al.. (2012). Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate. ACS Medicinal Chemistry Letters. 3(10). 823–827. 31 indexed citations
14.
Karbarz, Mark J., Lin Luo, Leon Chang, et al.. (2008). Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide Hydrolase. Anesthesia & Analgesia. 108(1). 316–329. 61 indexed citations
15.
Keith, John M., Richard L. Apodaca, Wei Xiao, et al.. (2008). Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 18(17). 4838–4843. 76 indexed citations
16.
Khan, Imran Mahmood, Michelle Wennerholm, Limin Zhang, et al.. (2004). Ablation of primary afferent terminals reduces nicotinic receptor expression and the nociceptive responses to nicotinic agonists in the spinal cord. Journal of Neurocytology. 33(5). 543–556. 16 indexed citations
17.
Ulfberg, Jan, et al.. (1977). Acute gastrointestinal haemorrhage. Experience with early panendoscopy and tranexamic acid in a rural hospital.. PubMed. 143(7-8). 463–8. 8 indexed citations
18.
Carling, L., et al.. (1976). Diagnosis and Treatment of Acute Gastrointestinal Haemorrhage in a Small District Hospital. Acta Medica Scandinavica. 199(1-6). 129–132. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ann M. Decker Breakdown of academic impact, for papers by Banu Cahide Tel Breakdown of academic impact, for papers by Giulia Donvito Breakdown of academic impact, for papers by K. Fukatsu Breakdown of academic impact, for papers by Amey Dhopeshwarkar Breakdown of academic impact, for papers by Leanne Cutler Breakdown of academic impact, for papers by Amaia M. Erdozain Breakdown of academic impact, for papers by Angela C. Doran Breakdown of academic impact, for papers by Sonya L. Palmer Breakdown of academic impact, for papers by Thomas F. Gamage
Rankless by CCL
2026